Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]The Netherlands Cancer Institute"
Count: 220
Selected: 0
NCT IDTitle
NCT04699292International Prospective Registry on Local Treatment Approaches in MLS
NCT04231175Dedicated MR Imaging vs Surgical Staging of Peritoneal Carcinomatosis in Colorectal Cancer
NCT01780675Hippocampus Avoidance PCI vs PCI
NCT03223727Treatment Outcomes in a Non-study Population of Symptomatic mCRPC Patients Treated With Radium-223
NCT03984019Cardiac Changes After Stereotactic Radiotherapy for Early Stage NSCLC Cancer or Lung Metastasis
NCT03772028Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
NCT04871594Checkpoint Inhibition With or Without Domatinostat in Urothelial Cancer
NCT04949113Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma
NCT03367780Dose-Effect Relation of Salivary Gland Irradiation
NCT01504815Adaptive Radiation Treatment for Head and Neck Cancer
NCT04425967Short Course Of Preoperative Radiotherapy in Head and Neck-, Trunk- and Extremity Soft Tissue Sarcomas
NCT04351204The MR-Linac Technical Feasibility Protocol
NCT03540563ctDNA as a Biomarker for Treatment Response in HNSCC
NCT02910895Sarcoma Patient Derived Xenografts
NCT02229656Olaparib and Radiotherapy in Head and Neck Cancer
NCT02227082Olaparib and Radiotherapy in Inoperable Breast Cancer
NCT02106312Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas
NCT04971421Liquid Biopsies for Improving the Pre-operative Diagnosis of Ovarian Cancer
NCT04161664Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel Chemotherapy
NCT04648189Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC
NCT02810743Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer
NCT01898117Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast Cancer
NCT02913729Pre- Versus Postoperative Accelerated Partial Breast Irradiation
NCT04916236Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers
NCT03348150Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination.
NCT03295565Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel
NCT04307329Monalizumab and Trastuzumab In Metastatic HER2-pOSitive breAst Cancer: MIMOSA-trial
NCT04017455Neoadjuvant Treatment in Rectal Cancer With Radiotherapy Followed by Atezolizumab and Bevacizumab (TARZAN)
NCT03448835Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)
NCT03026140Nivolumab, Ipilimumab and COX2-inhibition in Early Stage Colon Cancer: an Unbiased Approach for Signals of Sensitivity
NCT02695459Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary Origin
NCT03394716Monitoring MRI Changes Before and During Radiotherapy Treatment of Brain Tumors
NCT03387761Neo-Adjuvant Bladder Urothelial Carcinoma COmbination-immunotherapy
NCT03686332PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study
NCT02492607Management of Low-risk (Grade I and II) DCIS
NCT02925234The Drug Rediscovery Protocol (DRUP Trial)
NCT03871036Improve Checkpoint-blockade Response in Advanced Urothelial Cancer
NCT04287829Pembrolizumab Plus Lenvatinib In Second Line and Third Line Malignant Pleural mesotheLioma Patients
NCT03003637ImmunoModulation by the Combination of Ipilimumab and Nivolumab Neoadjuvant to Surgery In Advanced or Recurrent Head and Neck Carcinoma
NCT04737382Osimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed.
NCT02826512A Feasibility Study of Niraparib for Advanced, BRCA1-like, HER2-negative Breast Cancer Patients
NCT04148066ctDNA Guided Treatment of Early Resistance to Targeted Treatment
NCT01359397Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric Cancer
NCT04082988Early Response Evaluation in NSCLC Patients Treated With Immunotherapy
NCT04159818Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Patients
NCT03819829Blood Sampling of Healthy Volunteers for Immunological Research
NCT03815890Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO
NCT03147040AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer
NCT03126812Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer
NCT02914470Carboplatin-cyclophosphamide Combined With Atezolizumab